Notes - Significant Accounting Policies For Preparation Of Semi-Annual Consolidated Financial Statements

Mochida Pharmaceutical Co.,Ltd. - Filing #7709885

Concept As at
2019-03-31
2018-04-01 to
2019-03-31
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Notes - Significant accounting policies for preparation of semi-annual consolidated financial statements
Disclosure of scope of consolidation
Number of consolidated subsidiaries and names of major consolidated subsidiaries

1.連結の範囲に関する事項

当社の子会社は5社で全て連結しております。連結子会社名は、「第1 企業の概況 4.関係会社の状況」に記載のとおりであります。

 

Number of consolidated subsidiaries
5 xbrli:pure
Disclosure about application of equity method
Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method

2.持分法の適用に関する事項

該当事項はありません。

Disclosure about fiscal years, etc. of consolidated subsidiaries

3.連結子会社の事業年度等に関する事項

連結子会社の事業年度の末日は、連結決算日と一致しております。

 

Talk to a Data Expert

Have a question? We'll get back to you promptly.